Xcout IntelHuman Immunology Biosciences (Acquired)
Human Immunology Biosciences was a U.S. biotechnology company developing targeted immunotherapies for serious immune-mediated diseases. Its lead asset was felzartamab, an…
The full profile of Human Immunology Biosciences (Acquired)
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Human Immunology Biosciences (Acquired) →Already a subscriber? Sign in
Xcout Intel tracks Human Immunology Biosciences (Acquired) continuously — this profile deepens as new filings, funding, people and hiring data arrive.